Search  

 


 
 

LOMEFLOX

Lomefloxacin

 

Description:

Lomeflox (Lomefloxacin) is a synthetic fluoroquinolone anti-infective agent. It is active against a wide range of gram-negative and gram-positive organisms.

Presentation:

Each film coated tablet contains Lomefloxacin HCl equivalent to Lomefloxacin INN 400 mg.

Indications:

a) Treatment:

• Uncomplicated urinary tract infection.

• Complicated including recurrent and pyelonephritis, urinary tract infections.

• Acute exacerbation of chronic bronchitis.

• Skin and skin structure infection.

b) Prevention/Prophylaxis:

Lomeflox (Lomefloxacin) is indicated preperatively to prevent postoperative urinary tract infections in patients undergoing transurethral surgical procedures.

Dosage & Administration:

Lomeflox (Lomefloxacin)  is recommended at the doses and for the durations of treatment listed in the following table, and may be taken with or without food at bed time.

  Disorder Dose Duration or treatment
1. Typhoid fever  400 mg once daily or 200 mg b.i.d 10-14 days
2. Uncomplicated urinary tract infection   400 mg once dailyor 200 mg b.i.d 3 days
  Complicated urinary tract infection 400 mg once daily   or 200 mg b.i.d 10-14 days
  Diarrhoea due to  bacterial origin  400 mg once daily  or 200 mg b.i.d  5-7 days
  Acute exacerbation of chronic bronchitis  400 mg once daily  7-10 days
  Skin and skin  structure infections   400 mg once daily  10-14 days
  Prophylaxis of urinary tract infection following surgery   400 mg   Single dose 2-6 hours prior to transurethral surgery 

 

Contraindications:

Lomeflox (Lomefloxacin) is contraindicated in patients with a history of hypersensitivity to Lomeflox (Lomefloxacin) or to other quinolones. Lomeflox (Lomefloxacin), like other drugs in its class, cause arthropathy in juvenile animals. Therefore, its use in children, growing adolescents, and pregnant women is not recommended.

Precautions & Warnings:

Alterations of the dosage regimen is recommended for patients with impairment of renal function (Ccr<40ml/min/1.73 sq.m). Avoid exposure to excessive sunlight or artificial UV light. Phototoxicity reaction may occur if undue exposure occurs. Safety and efficacy of Lomeflox (Lomefloxacin) has not been established in children, pregnant and lactating women.

Drug Interaction:

Does not alter theophylline clearance and concentration. No change of caffeine is reported. Sucralfate and antacid containing magnesium and aluminium interfere with its bioavailability. Enhances effects of warfarin. Probenecid slows renal elimination of Lomeflox (Lomefloxacin) Side effects:

Nausea, headache, photosensitivity, dizziness, diarrhoea, dry mouth, fatigue, convulsions, CNS stimulation which may lead to tremors, restlessness, light headedness, confusion & hallucinations and pseudomembranous colitis.

Storage:

Store between 150 & 300 C. Protect from light.

Packing:

Box containing 2 x 10's in Alu-Alu blister pack.

Back to Top

Footer